Latest News
The SEAS Trial Debated
Medscape | 23 minutes ago
While numerous experts say the results provide little new information and won't alter clinical practice, some see the data as positive for Vytorin, especially in light of the wealth of evidence showing the benefit of lowering LDL-cholesterol levels.... (more)
Coventry earnings nearly halved, revenue jumps - MarketWatch
MarketWatch | 24 minutes ago
LOS ANGELES (MarketWatch) -- Coventry Health Care Inc.'s second-quarter earnings were cut in half, the company reported Friday, but revenue jumped by more than 21%, as the health insurer struggled to deal with rising medical costs.... (more)
Vendor Notebook - iMedica EHR gets CCHIT certification
Healthcare IT News | 29 minutes ago
Loading story... iMedica has announced that the Certification Commission for Healthcare Information Technology (CCHIT) has certified iMedica PRM 2008 version 8.1 as meeting the commission's criteria for 2007 ambulatory electronic health records. The Open eHealth Foundation (OeHF), an open-source initiative for the efficient exchange of medical information based on existing standards, has been officials registered as a nonprofit organization in Delaware. The organization was l...... (more)
ABC News: Drugs Add 13 Years to Lives of HIV Patients
ABC News | 1 hour 56 minutes ago
WASHINGTON (Reuters) - Cocktails of HIV drugs help patients live an average of 13 years longer -- if they are lucky enough to get them, researchers reported on Thursday.BRASILIA, BRAZIL: Bottles of Kaletra, of the Abbott Laboratories, are displayed at a pharmacy in... BRASILIA, BRAZIL: Bottles of Kaletra, of the Abbott Laboratories, are displayed at a pharmacy in Brasilia, 30 June 2005. Brazilian Health Minister Humberto Costa said Monday he was aiming to halve the cost of Kaletra, a key HIV...... (more)
Pfizer fined for lying about rival's products
Sydney Morning Herald, The | 2 hours 2 minutes ago
THE pharmaceutical giant Pfizer has been fined a record $200,000 after its representatives told doctors that a rival company's anti-cholesterol product was associated with kidney problems. - Sydney Morning Herald Online... (more)
Biological Functions of the Small Leucine-rich Proteoglycans: From Genetics to Signal Transduction*
Journal of Biological Chemistry | 2 hours 24 minutes ago
The small leucine-rich proteoglycan (SLRP) family has significantly expanded in the past decade to now encompass five discrete classes, grouped by common structural and functional properties.... (more)
Health Care Executives Place Higher Priority on Energy Efficiency Than Others, Research Shows
FacilitiesNet | 7 hours 15 minutes ago
Health care executives place a higher priority on energy efficiency than executives in other industries and are more likely to expect to make improvements over the coming year, according to recent surveys. ... (more)
Elyria's Invacare should benefit from suspension of Medicare bidding program
Plain Dealer (Cleveland), The | 7 hours 21 minutes ago
Friday, July 25, 2008 Mary Vanac Plain Dealer Reporter Last week's decision by Congress to postpone a competitive bidding program for medical equipment suppliers who work with Medicare could help Invacare Corp. next year.... (more)
Osiris stem cell line sale OK'd
Sun (Baltimore), The | 7 hours 43 minutes ago
Osiris Therapeutics' shareholders approved yesterday the sale of the stem cell drugmaker's only product line, a bone-regeneration treatment called Osteocel, in a transaction worth up to $137 million, which will be used for the company's next generation of drugs.... (more)
Ohio.com - OSU president's son-in-law dies of crash injuries
Akron Beacon Journal (Ohio) | 9 hours 44 minutes ago
Speeding downhill is uplifting... (more)
Harvard stem cell research gets boost
Boston Globe, The | 11 hours 3 minutes ago
British drug giant GlaxoSmithKline has agreed to sponsor at least $25 million in work at the Harvard Stem Cell Institute in Cambridge, one of the largest investments in stem cell research ever by a major pharmaceuticals company.... (more)
S&P Index to Add DaVitaJuly 25, 2008; Page C5
Wall Street Journal, The | 11 hours 8 minutes ago
NEW YORK -- Standard & Poor's said DaVita Inc. will replace Clear Channel Communications Inc. in the S&P 500-stock index after the close of trading on Wednesday, July 30.... (more)
Genentech Reviews Roche Takeover Bid
Wall Street Journal, The | 11 hours 8 minutes ago
Genentech Inc. said late Thursday it won't act on Roche Group AG's $89-a-share takeover bid until the deal is evaluated by a special committee of three members of its board.... (more)
305 Stories | 
RSS Feed
Sign up for AANP SmartBrief
Latest Blog Postsview more
Friday frolicks in Nawlins
Health Care Blog, The
Time and Tide
Stayin' Alive
Around the Web in 60 Seconds (Or Less)
Health Care Blog, The
Knol and web publishing challenge medical journals' hold on scientific publishing
Health Care Blog, The
Companies in the news
- Amgen Inc
- Amylin Pharmaceuticals Inc.
- Applied Biosystems Group
- Biogen IDEC Inc.
- Concord Hospital
- Genentech
- Georgetown University Hospital
- Hospitalist Company
- Merck & Co Inc
- Moses Taylor Hospital
- Perrigo Co
- Ranbaxy Laboratories Limited
- Roche Holding
- South Bend
- Spaulding Rehabilitation Hospital